Ticker Scorecard - VIR Basics Company: Vir Biotechnology, Inc. IPO Date: October 11, 2019 Sector: Healthcare Industry: Biotech Market Cap: $1.32B Activated in VL: True Average Daily Range Avg Daily Range: $0.94 | 3.18% Avg Daily Range (30 D): $0.30 | 2.82% Avg Daily Range (90 D): $0.28 | 3.14% Institutional Daily Volume Avg Daily Volume: .97M Avg Daily Volume (30 D): 2.43M Avg Daily Volume (90 D): 1.53M Trade Size Avg Trade Size (Sh.): 80 Avg Trade Size (Sh.) (30 D): 106 Avg Trade Size (Sh.) (90 D): 96 Institutional Trades Total Inst.Trades: 2,932 Avg Inst. Trade: $2.52M Avg Inst. Trade (30 D): $1.45M Avg Inst. Trade (90 D): $1.39M Avg Inst. Trade Volume: .11M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $3.89M Avg Closing Trade (30 D): $2.22M Avg Closing Trade (90 D): $1.67M Avg Closing Volume: 178.88K     News Jun 6, 2024 @ 5:29 PM Biotech Stock Roundup: GSK's Litigation Update, BI... Source: Zacks Equity Research Jun 6, 2024 @ 5:26 PM Vir Biotechnology (VIR) Up on Positive Data From H... Source: Zacks Equity Research May 24, 2024 @ 5:01 PM Evaluating Vir Biotechnology: Insights From 5 Fina... Source: Benzinga Insights May 7, 2024 @ 1:00 PM Deep Dive Into Vir Biotechnology Stock: Analyst Pe... Source: Benzinga Insights May 2, 2024 @ 10:05 PM Vir Biotechnology, Inc. (VIR) Reports Q1 Loss, Top... Source: Zacks Equity Research Financials   TTM Q2 2024 Q1 2024 Basic EPS $-1.56 $-1.02 $-.48 Diluted EPS $-1.56 $-1.02 $-.48 Revenue $ 2.38M $ 3.08M $ 56.38M Gross Profit $ 2.33M $ 3.02M $ 56.32M Net Income / Loss $ -213.72M $ -138.38M $ -65.28M Operating Income / Loss $ -231.3M $ -158.63M $ -80.08M Cost of Revenue $ .05M $ .05M $ .06M Net Cash Flow $ -52.85M $ 136.7M $ -80.82M PE Ratio